Gara Jalqabaatti › Darmaatomiyoosiitisiis › North Carolina › Durham
Qorannoo klinikaalii Darmaatomiyoosiitisiis Durham, NC keessatti
Qorannoo 8 Darmaatomiyoosiitisiis f Durham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Environmental Risk Factors for the Anti-synthetase Syndrome
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · Miili 7 fagaatti
Adult and Juvenile Myositis
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · Miili 7 fagaatti
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
Namoota walitti qabaa jiraSadarkaa 3
- Research Site, Durham
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Namoota walitti qabaa jiraSadarkaa 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · Miili 10 fagaatti
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
Namoota walitti qabaa jiraSadarkaa 1
- Research Site, Chapel Hill · Miili 10 fagaatti
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Namoota walitti qabaa jiraSadarkaa 1
- Duke University Medical Center, Durham
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Namoota walitti qabaa jiraSadarkaa 1
- Universtity of North Carolina at Chapel Hill, Chapel Hill · Miili 10 fagaatti
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
Namoota walitti qabaa jiraSadarkaa 1
- Duke University, Durham
Qorannoo Darmaatomiyoosiitisiis magaalota biroo keessatti
- Washington, DCQorannoo 7
- New York City, NYQorannoo 5
- Boston, MAQorannoo 5
- Pittsburgh, PAQorannoo 5
- Houston, TXQorannoo 5
- Miami, FLQorannoo 4
- Philadelphia, PAQorannoo 4
- Baltimore, MDQorannoo 4
- Aurora, COQorannoo 3
- Kansas City, KSQorannoo 3
- Jacksonville, FLQorannoo 3
- Phoenix, AZQorannoo 3
Qorannoo biroo Durham keessatti
- Saree OljooQorannoo 64
- Saree (Gosoota Hunda)Qorannoo 58
- Kansara Qara'a Non-Small CellQorannoo 39
- Myeloma Baay’eeQorannoo 37
- Leukemia Myeloidii HamaaQorannoo 33
- Kansara MetastatikiiQorannoo 33
- Kansarii ProstateQorannoo 32
- Dhibee QaraQorannoo 32
- Kansarii ColorectalQorannoo 28
- Kansarii OvariiQorannoo 27
- Luukemiya Limfoositiikii KeessummaaQorannoo 27
- Cufama OnneeQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.